Inventor · disambiguated record
Kevin D. Kreutter
Also filed as: KREUTTER KEVIN · KREUTTER KEVIN D · KREUTTER KEVIN DOUGLAS
41 granted patents·9 pending applications·189 citations·filing 2004–2024
97Inventor score
Files withJANSSEN PHARMACEUTICA NV38BAINDUR NAND2GAUL MICHAEL DAVID2NIMBUS CLOTHO INC2CHAKRAVARTY DEVRAJ1
Top patents by PatentIndex Score
50 records- 0196US9221804B2Secondary alcohol quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 29, 2015·35 cites·23 claims
- 0295US10487083B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 26, 2019·7 cites·12 claims
- 0395US10294226B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 21, 2019·11 cites·14 claims
- 0494US10364246B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 30, 2019·7 cites·9 claims
- 0593US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0693US11059823B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·4 cites·37 claims
- 0793US9290476B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 22, 2016·31 cites·27 claims
- 0891US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0991US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 1091US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 1191US7829584B2Pyridines and pyridine N-oxides as modulators of thrombinJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 9, 2010·12 cites·10 claims
- 1290US10954214B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 23, 2021·5 cites·37 claims
- 1390US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 1490US10369146B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 6, 2019·5 cites·13 claims
- 1589US10947252B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 16, 2021·3 cites·1 claims
- 1688US9284308B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 15, 2016·6 cites·21 claims
- 1787US11254673B2Small molecule inhibitors of NF-κB inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 22, 2022·2 cites·13 claims
- 1887US9309222B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 12, 2016·13 cites·25 claims
- 1986US7262210B2Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroarylsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 28, 2007·9 cites·8 claims
- 2086US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2185US9328095B2Heteroaryl linked quinolinyl modulators of RORgammatJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 3, 2016·3 cites·5 claims
- 2284US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 2384US9403816B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 2, 2016·3 cites·5 claims
- 2479US9624225B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 18, 2017·3 cites·10 claims
- 2579US9303015B2Heteroaryl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·4 cites·24 claims
- 2677US9346782B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 24, 2016·3 cites·6 claims
- 2776US11040031B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 22, 2021·2 cites·9 claims
- 2875US12202831B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 21, 2025·0 cites·11 claims
- 2974US11427601B1Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 30, 2022·0 cites·44 claims
- 3070US7825244B2Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesisJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Nov 2, 2010·1 cites·12 claims
- 3167US11897900B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 13, 2024·0 cites·17 claims
- 3265US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 3364US12077521B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 3464US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 3563US2025197388A1Compounds, pharmaceutical compositions and methods for treating inflammatory bowel diseaseFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 3661US8748624B2Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 10, 2014·1 cites·22 claims
- 3760US2009143378A1Thienopyrimidine and thienopyridine kinase modulatorsGAUL MICHAEL DAVID·Filed 2009·Application pending·0 cites
- 3860US2009163710A1Thienopyrimidine and thienopyridine kinase modulatorsGAUL MICHAEL DAVID·Filed 2009·Application pending·0 cites
- 3958US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 4053US2006281768A1Thienopyrimidine and thienopyridine kinase modulatorsGAUL MICHAEL D·Filed 2006·Application pending·0 cites
- 4152US2025270200A1Ctps1 inhibitors and uses thereofNIMBUS CLOTHO INC·Filed 2023·Application pending·0 cites
- 4251US2016136149A1HETEROARYL LINKED QUINOLINYL MODULATORS OF RORytJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 4350US2024262830A1Ire1a modulators and uses thereofNIMBUS IASO INC·Filed 2021·Application pending·0 cites
- 4449US10201546B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 12, 2019·0 cites·18 claims
- 4546US12331046B2CTPS1 inhibitors and uses thereofNIMBUS CLOTHO INC·Filed 2021·Granted Jun 17, 2025·0 cites·10 claims
- 4645US11492341B2ACLY inhibitors and uses thereofNIMBUS ARTEMIS INC·Filed 2019·Granted Nov 8, 2022·0 cites·8 claims
- 4744US7550474B2Substituted phenyl acetamides and their use as protease inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jun 23, 2009·0 cites·42 claims
- 4843US10555941B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Feb 11, 2020·0 cites·16 claims
- 4936US8071768B2Alkylquinoline and alkylquinazoline kinase modulatorsBAINDUR NAND·Filed 2006·Granted Dec 6, 2011·0 cites·12 claims
- 5035US2007004763A1Aminoquinoline and aminoquinazoline kinase modulatorsBAINDUR NAND·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin D. Kreutter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →